Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Seah H. Lim, MD, PhD, William V. Esler, MD, Yana Zhang, MD. PhD, Jian Zhang, BS, Phillip O. Periman, MD, Colleen Burris, RN, OCN, Mary Townsend, MD

Blood (2007) 110 (11): 4480.

https://doi.org/10.1182/blood.V110.11.4480.4480

Published: 2007

Journal Articles

Autologous Stem Cell Transplant Followed by Low Dose Rituxan Maintenance in CR1 Is Effective for the Treatment of Mantle Cell Lymphoma.

Seah H. Lim, MD, PhD, William V. Esler, MD, David Beggs, MD, Colleen Burris, RN, OCN, Yana Zhang, MD, PhD, Mary Townsend, MD

Blood (2006) 108 (11): 5427.

https://doi.org/10.1182/blood.V108.11.5427.5427

Published: 2006

Journal Articles

Adult Mismatched Umbilical Cord Blood Transplant Is Feasible in a Community Setting for an Unselected Group of High Risk Patients.

Seah H. Lim, MD, PhD, William V. Esler, MD, David Beggs, MD, Colleen Burris, RN, OCN, Yana Zhang, MD, PhD, Mary Townsend, MD

Blood (2006) 108 (11): 5391.

https://doi.org/10.1182/blood.V108.11.5391.5391

Published: 2006

Journal Articles

Rituximab Administration Following Autologous Stem Cell Transplant for Multiple Myeloma Is Associated with Severe IgM Deficiency.

Seah H. Lim, MD, PhD, Yana Zhang, MD, PhD, Zhiqing Wang, PhD, Rupa Varadarajan, MD, Phillip O. Periman, MD, William V. Esler, MD

Blood (2004) 104 (11): 4897.

https://doi.org/10.1182/blood.V104.11.4897.4897

Published: 2004

Journal Articles

Attitude towards Cancer Treatment in Patients Attending a Community Cancer Center.

James E. Rohrer, PhD, Qassam Saeed, MD, Samreen Saeed, MD, William V. Esler, MD, David Beggs, MD, Phillip O. Periman, MD, Paul Hancock, MD, Seah H. Lim, MD, PhD

Blood (2004) 104 (11): 3143.

https://doi.org/10.1182/blood.V104.11.3143.3143

Published: 2004

Journal Articles

Maintenance Rituximab after Autologous Stem Cell Transplant for High-Risk B-Cell Lymphoma Induces Prolonged and Severe Hypogammaglobulinemia.

Seah H. Lim, MD, PhD, Yana Zhang, MD, PhD, Zhiqing Wang, PhD, William V. Esler, MD, David Beggs, MD, Brian Pruitt, MD, Paul Hancock, MD, Mary Townsend, MD

Blood (2004) 104 (11): 1408.

https://doi.org/10.1182/blood.V104.11.1408.1408

Published: 2004

NARROW

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Autologous Stem Cell Transplant Followed by Low Dose Rituxan Maintenance in CR1 Is Effective for the Treatment of Mantle Cell Lymphoma.

Adult Mismatched Umbilical Cord Blood Transplant Is Feasible in a Community Setting for an Unselected Group of High Risk Patients.

Rituximab Administration Following Autologous Stem Cell Transplant for Multiple Myeloma Is Associated with Severe IgM Deficiency.

Attitude towards Cancer Treatment in Patients Attending a Community Cancer Center.

Maintenance Rituximab after Autologous Stem Cell Transplant for High-Risk B-Cell Lymphoma Induces Prolonged and Severe Hypogammaglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Autologous Stem Cell Transplant Followed by Low Dose Rituxan Maintenance in CR1 Is Effective for the Treatment of Mantle Cell Lymphoma.

Adult Mismatched Umbilical Cord Blood Transplant Is Feasible in a Community Setting for an Unselected Group of High Risk Patients.

Rituximab Administration Following Autologous Stem Cell Transplant for Multiple Myeloma Is Associated with Severe IgM Deficiency.

Attitude towards Cancer Treatment in Patients Attending a Community Cancer Center.

Maintenance Rituximab after Autologous Stem Cell Transplant for High-Risk B-Cell Lymphoma Induces Prolonged and Severe Hypogammaglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only